Koskinas, K C; Gencer, B.; Raeber, L; Karagiannis, A.; Nanchen, D.; Carballo, D.; Carballo, S.; Klingenberg, R.; Heg, D; Matter, C.; Luscher, T.F.; Rodondi, N; Windecker, S; Mach, F. (August 2017). P169 Eligibility for PCSK9 inhibitors according to ESC/EAS and ACC recommendations after acute coronary syndromes. European Heart Journal, 38(suppl_1), ehx501.P169. Oxford University Press 10.1093/eurheartj/ehx501.P169
|
Text
Koskinas EurHeartJSuppl 2017_abstract.pdf - Published Version Available under License Publisher holds Copyright. Download (141kB) | Preview |
Official URL: https://academic.oup.com/eurheartj/article/38/supp...
Item Type: |
Conference or Workshop Item (Poster) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology 04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine > Centre of Competence for General Internal Medicine 04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM) |
UniBE Contributor: |
Koskinas, Konstantinos, Räber, Lorenz, Heg, Dierik Hans, Rodondi, Nicolas, Windecker, Stephan |
Subjects: |
600 Technology > 610 Medicine & health 300 Social sciences, sociology & anthropology > 360 Social problems & social services |
ISSN: |
0195-668X |
Publisher: |
Oxford University Press |
Language: |
English |
Submitter: |
Doris Kopp Heim |
Date Deposited: |
30 Jan 2018 14:59 |
Last Modified: |
05 Dec 2022 15:10 |
Publisher DOI: |
10.1093/eurheartj/ehx501.P169 |
BORIS DOI: |
10.7892/boris.110533 |
URI: |
https://boris.unibe.ch/id/eprint/110533 |
Actions (login required)
 |
Edit item |